Doctor profile · Federal record

Dr. Masoud Khorsand-Sahbaie, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Roswell, NM

  • NPI 1629066097
  • Accepts Medicare
  • MIPS 76.9 / 100 · 2023
  • 37 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
407 W Country Club RD
Roswell, NM 882015209
(575) 627-9110
fax (575) 627-9535
Mailing address
Po Box 1574
Roswell, NM 882021574

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
January 26, 2017
Year of graduation
1989 — 37 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
New Mexico #96299
Medicaid
NM #P6399

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1629066097. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
72,393
Distinct HCPCS
10
Medicare allowed
$1,563,053
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 26,250 16 $1
J9271 Injection, pembrolizumab, 1 mg 16,000 14 $53
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 3,380 13 $8
36415 Insertion of needle into vein for collection of blood sample 3,357 1,291 $7
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 2,658 1,046 $8
J0897 Injection, denosumab, 1 mg 2,640 13 $20
80053 Blood test, comprehensive group of blood chemicals 2,180 1,034 $10
83615 Lactate dehydrogenase (enzyme) level 1,207 409 $6
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,130 25 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 907 280 $121

In context: peer comparison

Among 2 peers in this city , average services per provider: 774. This provider delivers 94× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$449
Transactions
21
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Merck Sharp & Dohme LLC 3 $52.74
Siemens Medical Solutions USA, Inc. 1 $51.09
Novartis Pharmaceuticals Corporation 2 $50.74
Celgene Corporation 2 $34.06
Regeneron Healthcare Solutions, Inc. 1 $29.43
AstraZeneca Pharmaceuticals LP 2 $28.14
PFIZER INC. 2 $27.42
Alexion Pharmaceuticals, Inc. 1 $26.06
SERVIER PHARMACEUTICALS LLC 1 $22.01
Daiichi Sankyo Inc. 1 $18.20
Karyopharm Therapeutics Inc. 1 $18.10
Eisai Inc. 1 $17.81
Immunocore Limited 1 $15.77
SOBI, INC 1 $14.92
Gilead Sciences, Inc. 1 $14.59

By nature of payment

Food and Beverage
$449

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
734
Patients
247
Total drug cost
$106,049
Drug Type Claims Patients Total cost
Anastrozole Generic 145 38 $3,932
Potassium Chloride Generic 60 29 $999
Prednisone Generic 60 20 $384
Prochlorperazine Maleate Generic 56 44 $768
Dexamethasone Generic 54 13 $741
Letrozole Generic 51 16 $1,298
Allopurinol Generic 44 13 $410
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 43 25 $1,126
Valacyclovir (Valacyclovir Hcl) Brand 42 12 $1,310
Ondansetron Odt (Ondansetron) Brand 36 24 $394

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Masoud Khorsand-Sahbaie's medical specialty?
Dr. Masoud Khorsand-Sahbaie practices Hematology & Oncology Physician in Roswell, NM.
Where does Dr. Masoud Khorsand-Sahbaie practice?
Dr. Masoud Khorsand-Sahbaie practices at 407 W Country Club RD, Roswell, NM 882015209. Office phone: 5756279110.
What is Dr. Masoud Khorsand-Sahbaie's NPI?
Dr. Masoud Khorsand-Sahbaie's National Provider Identifier (NPI) is 1629066097, issued by NPPES.
Does Dr. Masoud Khorsand-Sahbaie accept Medicare assignment?
Yes. Dr. Masoud Khorsand-Sahbaie accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Masoud Khorsand-Sahbaie commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885). Source: CMS Medicare Physician & Other Practitioners file.